What are the current recommendations for preventing and managing complications associated with mechanical ventilation?

Complications of Mechanical Ventilation: Prevention and Management

The most critical approach to preventing mechanical ventilation complications is implementing lung-protective ventilation with low tidal volumes (4-8 mL/kg predicted body weight) and plateau pressures <30 cm H₂O, combined with a comprehensive VAP prevention bundle that includes avoiding intubation when possible, minimizing sedation, head-of-bed elevation to 30-45°, and oral care with toothbrushing without chlorhexidine. 1

Ventilator-Induced Lung Injury (VILI) Prevention

Lung-Protective Ventilation Strategy

• Use low tidal volumes of 4-8 mL/kg predicted body weight (males = 50 + 0.91[height (cm) - 152.4] kg; females = 45.5 + 0.91[height (cm) - 152.4] kg) 1
• Maintain plateau pressures below 30 cm H₂O to prevent barotrauma 1
• Meta-regression demonstrates that larger tidal volume gradients (greater difference between low and traditional volumes) show significantly lower mortality risk, with trials achieving mean tidal volumes of 6.8 mL/kg PBW showing benefit 1
• This remains the cornerstone intervention, as mechanical ventilation itself can cause and potentiate lung injury contributing to organ failure and mortality 1, 2

Ventilator-Associated Pneumonia (VAP) Prevention Bundle

Primary Prevention Strategies (High to Moderate Quality Evidence)

Avoid intubation and minimize ventilator exposure:

• Use high-flow nasal oxygen or noninvasive positive pressure ventilation whenever safe and feasible 1
• Implement ventilator liberation protocols to minimize duration of mechanical ventilation 1

Sedation management:

• Minimize sedation using protocols 1
• Avoid benzodiazepines in favor of alternative agents 1

Physical positioning and mobility:

• Elevate head of bed to 30-45 degrees (though quality of evidence is low, this remains standard practice) 1
• Initiate early exercise and mobilization programs, which can decrease ventilation duration, ICU length of stay, and VAP incidence 1

Oral care:

• Provide oral care with toothbrushing but WITHOUT chlorhexidine (moderate quality evidence shows chlorhexidine is not advisable) 1
• This represents an important update, as chlorhexidine oral care is now explicitly not recommended 1

Nutritional support:

• Provide early enteral nutrition rather than parenteral nutrition (high quality evidence) 1

Equipment management:

• Change ventilator circuits only if visibly soiled or malfunctioning, not on scheduled basis 1
• Use continuous cuff pressure control 1

Interventions NOT Recommended (Moderate Quality Evidence)

The 2025 ISID guidelines explicitly advise against several previously considered interventions 1:

• Ultrathin polyurethane ETT cuffs
• Tapered ETT cuffs
• Kinetic beds
• Prone positioning (for VAP prevention specifically)
• Chlorhexidine bathing
• Stress-ulcer prophylaxis
• Monitoring residual gastric volumes
• Early parenteral nutrition
• Automated control of ETT cuff pressure
• Oral care with chlorhexidine

Common Complications to Monitor

Infectious Complications

• Ventilator-associated pneumonia remains the most prevalent serious complication requiring surveillance using CDC/NHSN definitions 1, 3, 4
• Calculate VAP rates as number of VAPs divided by total MV-days × 1000 1
• Stratify rates by patient-care unit type and compare with historical and benchmark data 1

Non-Infectious Complications

Common complications include 3, 5:

• Atelectasis
• Post-extubation stridor
• Perioral tissue damage
• Mucus plugging
• Pneumothorax and pneumomediastinum
• ICU neuromyopathy
• Acute respiratory distress syndrome
• Pulmonary edema
• Pleural effusion

Quality Monitoring and Compliance

Implement documented checklists:

• Use MV connection and maintenance checklists across all settings 1
• Assign knowledgeable healthcare professionals to oversee compliance 1
• Calculate compliance by dividing number of times each recommendation was followed by total opportunities 1

Track device utilization ratio (DUR):

• Monitor longitudinally as surrogate for patient exposure risk 1
• Calculate as observed MV-days divided by observed patient days 1
• Compare at hospital and unit levels using CDC/NHSN and INICC international data 1

Critical Pitfalls to Avoid

• Do not use traditional high tidal volumes (10-15 mL/kg PBW), as this significantly increases mortality risk when compared to lung-protective strategies 1
• Do not use chlorhexidine for oral care, despite its previous widespread recommendation—current evidence shows it should be avoided 1
• Do not delay implementation of early mobilization, as this multifaceted approach decreases VAP incidence and improves functional outcomes 1
• Do not continue mechanical ventilation longer than necessary—minimize exposure through liberation protocols and consider noninvasive alternatives 1